Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer
- PMID: 37006229
- PMCID: PMC10051132
- DOI: 10.2144/fsoa-2022-0032
Exosomes as crucial emerging tools for intercellular communication with therapeutic potential in ovarian cancer
Abstract
More than two-thirds of epithelial ovarian cancer (EOC) patients are diagnosed at advanced stages due to the lack of sensitive biomarkers. Currently, exosomes are intensively investigated as non-invasive cancer diagnostic markers. Exosomes are nanovesicles released in the extracellular milieu with the potential to modulate recipient cells' behavior. EOC cells release many altered exosomal cargoes that exhibit clinical relevance to tumor progression. Exosomes represent powerful therapeutic tools (drug carriers or vaccines), posing a promising option in clinical practice for curing EOC in the near future. In this review, we highlight the importance of exosomes in cell-cell communication, epithelial-mesenchymal transition (EMT), and their potential to serve as diagnostic and prognostic factors, particularly in EOC.
Keywords: biomarkers; cell-free messengers; exosomes; molecular cargo; ovarian cancer.
Plain language summary
Exosomes are nanovesicles released in the extracellular milieu by diverse cell types and serve as carriers of proteins, and nucleic acids, with the potential to modulate the recipient cells. Understanding the functions of exosomes as messengers between cancer and healthy cells unfolds new avenues in intercellular signaling mechanisms. In this review, we have highlighted the importance of exosomes in cell–cell communication and their potential to serve as diagnostic and prognostic factors in EOC. Furthermore, we believe that exosomes could represent a powerful therapeutic tool due to their ability to function as drug carriers or vaccines posing a promising option in curing EOC.
© 2023 The Authors.
Figures
Similar articles
-
Diagnostic and prognostic relevance of circulating exosomal miR-373, miR-200a, miR-200b and miR-200c in patients with epithelial ovarian cancer.Oncotarget. 2016 Mar 29;7(13):16923-35. doi: 10.18632/oncotarget.7850. Oncotarget. 2016. PMID: 26943577 Free PMC article.
-
Exosomal Metastasis‑Associated Lung Adenocarcinoma Transcript 1 Promotes Angiogenesis and Predicts Poor Prognosis in Epithelial Ovarian Cancer.Int J Biol Sci. 2018 Nov 1;14(14):1960-1973. doi: 10.7150/ijbs.28048. eCollection 2018. Int J Biol Sci. 2018. PMID: 30585260 Free PMC article.
-
The multifaceted role of exosomes in cancer progression: diagnostic and therapeutic implications [corrected].Cell Oncol (Dordr). 2018 Jun;41(3):223-252. doi: 10.1007/s13402-018-0378-4. Epub 2018 Apr 17. Cell Oncol (Dordr). 2018. PMID: 29667069 Review.
-
TWEAK-stimulated macrophages inhibit metastasis of epithelial ovarian cancer via exosomal shuttling of microRNA.Cancer Lett. 2017 May 1;393:60-67. doi: 10.1016/j.canlet.2017.02.009. Epub 2017 Feb 16. Cancer Lett. 2017. PMID: 28216373
-
The role of exosomes in cancer biology by shedding light on their lipid contents.Pathol Res Pract. 2023 Oct;250:154813. doi: 10.1016/j.prp.2023.154813. Epub 2023 Sep 12. Pathol Res Pract. 2023. PMID: 37769395 Review.
Cited by
-
The paradigm of stem cell secretome in tissue repair and regeneration: Present and future perspectives.Wound Repair Regen. 2025 Jan-Feb;33(1):e13251. doi: 10.1111/wrr.13251. Wound Repair Regen. 2025. PMID: 39780313 Free PMC article. Review.
-
Alternative therapeutic strategies in diabetes management.World J Diabetes. 2024 Jun 15;15(6):1142-1161. doi: 10.4239/wjd.v15.i6.1142. World J Diabetes. 2024. PMID: 38983831 Free PMC article. Review.
-
Exosomes in ovarian cancer: Impact on drug resistance and advances in SERS detection techniques.J Pharm Anal. 2025 Jul;15(7):101170. doi: 10.1016/j.jpha.2024.101170. Epub 2024 Dec 18. J Pharm Anal. 2025. PMID: 40757000 Free PMC article. Review.
-
Exploring the Role of Extracellular Vesicles in Skeletal Muscle Regeneration.Int J Mol Sci. 2024 May 27;25(11):5811. doi: 10.3390/ijms25115811. Int J Mol Sci. 2024. PMID: 38892005 Free PMC article. Review.
-
Cell Homing Strategies in Regenerative Endodontic Therapy.Cells. 2025 Jan 29;14(3):201. doi: 10.3390/cells14030201. Cells. 2025. PMID: 39936992 Free PMC article. Review.
References
-
- Le Page C, Provencher D, Maugard CM, Ouellet V, Mes-Masson A-M. Signature of a silent killer: expression profiling in epithelial ovarian cancer. Expert Rev. Mol. Diagn. 4(2), 157–167 (2004). - PubMed
-
- Agarwal R, Kaye SB. Ovarian cancer: strategies for overcoming resistance to chemotherapy. Nat. Rev. Cancer. 3(7), 502–516 (2003). - PubMed
Publication types
LinkOut - more resources
Full Text Sources